The Cure Sickle Cell Initiative seeks to develop cures for a far broader group of individuals with the disease, and it is initially focusing on gene therapies that modify the patient’s own hematopoietic stem cells (HSCs), which make red and other blood cells.
Featured

NIH launches initiative to accelerate genetic therapies to cure sickle cell disease

“This initiative is giving patients, families, and communities a reason for hope. I’m particularly pleased that we are able to make this announcement during Sickle Cell Awareness month, when we are shining a spotlight on the toll of this devastating disease,” — ADM Brett Giroir, M.D. Asst. Sec. for Health, U.S. Dept. of Health & Human Services (HHS) […read more]

Black History

PRESS ROOM: Pfizer and the National Newspaper Publishers Association Collaborate to Raise Awareness of Sickle Cell Disease and Need for Improved Patient Care

Media Contacts: Steven Danehy 212-733-1538 Steven.Danehy@pfizer.com Claudette Perry 212-588-8764 Ext. 2 cperry@nnpa.org Collaboration Aims to Educate on the Importance of Clinical Trials in Developing Potential New Sickle Cell Disease Therapies NEW YORK, NY, March 24, 2017 – Pfizer Inc. (NYSE:PFE) and the National Newspaper Publishers Read More